Healthcare Symposium

Posted on October 24, 2008 at 1:56 PM
Filed under: Dealscape | Events | Healthcare Symposium | The Deal's Events

Nathaniel Zilkha of Kohlberg Kravis Roberts & Co. on the rising costs of managed care and healthcare reform. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 8, 2008 at 3:01 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

A partner at Weil, Gotshal & Manges, Fiona Schaeffer specializes in antitrust counseling, litigation and transactional matters. She is also a vice chair of the International Antitrust Committee of the ABA's Section of Antitrust Law; and a co-chair of the International Antitrust Committee of the ABA's Section of International Law. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 8, 2008 at 2:40 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

David P. Wales is Deputy Director of the Federal Trade Commission's Bureau of Competition. Prior to joining the FTC, he was a partner in the antitrust practice group of Cadwalader, Wickersham & Taft LLP, handling antitrust litigation, mergers and acquisitions, joint ventures, distribution arrangements, competitor collaborations and grand jury investigations. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 7, 2008 at 2:56 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

Richard J. Zall is a partner at Proskauer Rose LLP and Chair of the firm's Health Industry practice group. His practice is focused on corporate and regulatory representation of health care clients, including academic medical centers, hospitals, and physician organizations; information technology and medical device companies; managed care and health benefit management companies; and private equity firms.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 7, 2008 at 2:32 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

David Wales, Deputy Director, of the Bureau of Competition Federal Trade Commission discusses how the federal trade commission evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The Deal's Healthcare Dealmaking Symposium.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 5, 2008 at 2:15 PM
Filed under: Corporate Dealmaker | Healthcare Symposium | The Deal's Events

Chul Pak is a partner at Wilson Sonsini, Goodrich & Rosati and a former assistant director of the Mergers IV Division at the Federal Trade Commission. In this clip Pak discussses the regulatory outlook for healthcare deals over the next year at The Healthcare Dealmaking Symposium.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 4, 2008 at 4:42 PM
Filed under: Corporate Dealmaker | Healthcare Symposium | The Deal's Events

Prior to Omnicare, Christine Arakelian led corporate development positions at Neighborcare and Alpharma. She is a corporate and licensing attorney, with a J.D. from the University of Virginia and a B.A. with honors from the University of Pennsylvania. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 4, 2008 at 2:34 PM
Filed under: Dealscape | Healthcare Symposium | The Deal's Events

A Principal at KKR, Nathaniel Zilkha focuses on investments in healthcare. Prior to joining KKR, he led the healthcare investing efforts for the Goldman Sachs Capital Partners funds. Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 3, 2008 at 4:25 PM
Filed under: Corporate Dealmaker | Healthcare Symposium | The Deal's Events

Omnicare's Arakelian on the advantages deep-pocketed strategic buyers are enjoying due to the credit crunch at The Deal's Healthcare Dealmaking Symposium. Continue reading

[ Share ]  [ E-mail]  [ Comments (1) ]  [ Full Story ]

Posted on April 3, 2008 at 4:14 PM
Filed under: Behind the Money | Healthcare Symposium | Tech Confidential

Claudia Fan Munce, managing director of IBM Corp.'s Venture Capital Group discusses how IBM partners with venture capital groups and works with cleantech startups.  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]